NCT05699746 - CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

Colorectal Cancer

Interventions

DRUG

Capecitabine tablets

Capecitabine 1000 mg/m2, twice daily PO for 14 days, repeat every 3 weeks, for at most 8 cycles.

DRUG

Oxaliplatin

Oxaliplatin 130 mg/m2 IV day 1, combined with Capecitabine, for at most 8 cycles.

Trial Locations (4)

Changhai Hospital of Shanghai, Shanghai

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

Second Affiliated Hospital Zhejiang University College of Medicine, Hangzhou

The second hospital of Ningbo City, Ningbo